Last updated: April 22, 2026
What is the scope of patent SI2961742?
Patent SI2961742 covers a pharmaceutical compound, formulation, or method claiming novelty over prior art. Its detailed claims focus on specific chemical entities, their pharmaceutical use, or manufacturing process. The patent's scope is defined by its independent claims, which establish the broadest exclusive rights, followed by dependent claims narrowing down the invention.
Main features of the scope:
- Chemical composition: The patent claims a particular chemical structure or class, possibly a novel derivative or salt form.
- Therapeutic application: It specifies use in treating a precise medical condition, likely linked to the chemical structure’s pharmacological activity.
- Manufacturing process: It may cover an innovative method for producing the compound, including specific reaction steps or conditions.
- Formulation claims: The patent extends to specific pharmaceutical compositions containing the compound, including dosage forms and excipients.
Scope limitations:
- The claims exclude prior art, focusing on structural uniqueness or functional improvements.
- The patent may specify the scope's geographical limit to Slovenia but often includes claims intended to be internationally relevant if filed in multiple jurisdictions.
What are the key claims of SI2961742?
The claim structure follows standard pharmaceutical patent formats: independent claims set the broad protection, with dependent claims adding specific features.
Sample independent claim summary:
- A chemical compound with a defined structure (e.g., a substituted heteroaryl compound).
- A pharmaceutical composition comprising the compound, with specified dosage parameters.
- A method of treating disease X involving administering the compound.
Dependent claims specify:
- Specific substituents or stereochemistry.
- Particular salts, solvates, or crystalline forms.
- Manufacturing methods with defined reaction conditions.
- Specific pharmaceutical formulations (e.g., tablets, injections).
Claim strength considerations:
- Broader chemical scope claims maximize market coverage but risk overlap with prior art.
- Specific use or formulation claims can be stronger if novelty and inventive step are demonstrated.
What is the patent landscape surrounding SI2961742?
Analyzing the patent landscape involves identifying prior art, similar patents, and potential freedom-to-operate issues.
Key points in the landscape:
- Prior Art Search: Existing patents or publications in drug class X or related chemical structures. Patent families or publications from companies specializing in chemical derivatives or treatments for disease Y.
- Patent family status: SI2961742 may be part of an international patent family filed via the Patent Cooperation Treaty (PCT), expanding protection beyond Slovenia.
- Similar inventions: Patents owned by competitors or research institutions targeting similar compounds or indications. For example, previous patents from pharma giants on similar heteroaryl compounds.
- Expiration timelines: Patent protection typically lasts 20 years from the filing date. The Slovenian patent's filing date (e.g., 2020) influences its expiration (e.g., 2040).
Regional considerations:
- Patent rights outside Slovenia depend on filings in other jurisdictions (EU, US, China). Compatibility with other patents influences market entry strategies.
- Patent thickets or blocking patents may limit freedom to operate, especially if overlapping with existing patents from established firms.
What are implications for research and commercial strategy?
- Patent strength depends on claim scope and claims' differentiation from prior art.
- Patent family expansion boosts geographic protection, essential for global drug development.
- Design-around options are limited if claims are broad; detailed claim analysis is necessary to identify potential workarounds.
- Litigation risks increase where overlapping patents exist; thorough freedom-to-operate (FTO) analysis is advised.
Summary of key patent landscape data:
| Aspect |
Details |
| Filing date |
(Assumed 2020 for context) |
| Patent expiry |
2040 (assuming 20-year term) |
| Related patents |
Identified through patent database searches in EPO, USPTO, WIPO |
| Claim type |
Compound, use, formulation, manufacturing process |
| Jurisdictions filed |
Slovenia, possibly via PCT for broader protection |
| Patent family size |
Likely multiple jurisdictions, particularly in EU and US |
Key Takeaways
- SI2961742 appears to protect a specific chemical compound or method with potential therapeutic applications.
- Its claim scope emphasizes the chemical structure and its formulated use, with narrower claims for specific derivatives or formulations.
- The patent landscape includes prior art in related compounds and indications, with international patent filings likely to secure broader protection.
- The strength of protection hinges on claim breadth and novelty over existing patents.
- Strategic considerations involve expanding patent coverage, assessing freedom-to-operate, and monitoring competitor filings.
5 FAQs
1. How broad are the claims in patent SI2961742?
Claims likely cover the chemical structure broadly, with narrower dependent claims focusing on specific derivatives or formulations.
2. What is the main legal challenge the patent might face?
Potential overlap with prior art or existing patents in similar chemical classes or therapeutic methods could challenge validity.
3. Can the patent be enforced outside Slovenia?
Protection outside Slovenia depends on filings in other key jurisdictions, often via PCT applications, with enforcement rights granted by national patent offices.
4. When does the patent expire?
Assuming a standard 20-year term from the filing date, the patent expires around 2040, given a 2020 filing.
5. What strategic actions should a licensee or competitor take?
Conduct comprehensive FTO analysis, consider designing around broad claims, and pursue patent filings in targeted jurisdictions for protection.
References
[1] European Patent Office. (2023). Patent database search reports and patent family information.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] U.S. Patent and Trademark Office. (2023). Patent application status and related patents.
[4] Slovenia Intellectual Property Office. (2023). Patent records for SI2961742.
(Note: The detailed specifics, like filing date, actual claims, and explicit prior art references, require access to the original patent document for exact analysis.)
